Summary of Board Meeting Outcomes

1. Appointment of Additional Director

The Board approved the appointment of Mr. Ravi Kanth Naga Pattabhi Chopperla (DIN: 06812649) as an Additional Director in the category of Professional and Non-Executive with effect from 04.07.2026. This appointment is subject to approval by shareholders.

Director Profile: Mr. Chopperla has over 18 years of experience in investor relations, corporate advisory, business transformation, and financial services. He currently serves as Executive Director & Chief Operating Officer of QROPS Advisory Services Private Limited and as a Non-Executive Director of ECI Systems Private Limited. He holds an MBA in Marketing from Dravidian University and is a Certified Independent Director.

Shareholding: Mr. Chopperla holds 16,16,001 equity shares (7.1%) in the company.

2. Scheme of Capital Reduction

The Board approved a Scheme of Reduction of Capital under Section 66 read with Section 52 and other applicable provisions of the Companies Act, 2013.

Details of Reduction:

  • Cancellation of 11,37,48,550 fully paid-up equity shares of ₹10 each on a pro-rata basis
  • Current paid-up equity share capital: ₹22,74,97,100 (2,27,49,710 equity shares of ₹10 each)
  • Post-reduction paid-up equity share capital: ₹11,37,48,550 (1,13,74,855 equity shares of ₹10 each)

Financial Impact:

  • Amount of ₹11,37,48,550 will be set off against accumulated losses and share premium balance totaling ₹11,57,66,110
  • This will result in significant reduction of accumulated losses and cancellation of entire share premium amount
  • The relative shareholding percentages of all continuing shareholders will remain unchanged
  • No consideration will be paid to shareholders for the cancelled shares

Approvals Required: The Scheme is subject to approval from shareholders, the Hyderabad Bench of the National Company Law Tribunal (NCLT), and other statutory/regulatory approvals. BSE Limited has been nominated as the Designated Stock Exchange for the purpose of the Scheme.

3. Alteration of Memorandum of Association

The Board approved alteration of the Main Object Clause by inserting a new sub-clause 5 under Clause III(A), subject to shareholder approval by Special Resolution.

New Business Object: To carry on the business of pet animal healthcare and wellness, including establishing, operating, managing and providing veterinary, diagnostic, preventive, curative, therapeutic, rehabilitation, grooming, nutrition, wellness and allied services for pet and companion animals; and to manufacture, formulate, develop, purchase, sell, distribute, import, export and otherwise deal in veterinary medicines, pharmaceuticals, nutraceuticals, pet foods, animal healthcare products, medical devices, grooming products, accessories and all other products and services related to pet animal healthcare, wellness and animal welfare.

4. Related Party Transactions

The Board approved proposal for entering into Related Party Transactions with QROPS Advisory Services Private Limited (an Associate Company), subject to shareholder approval in accordance with Companies Act, 2013 and SEBI Listing Regulations.

5. Annual General Meeting

  • Directors Report for Financial Year 2025-26 and notice for AGM approved
  • Annual General Meeting scheduled for Monday, 10 August 2026 at 11:00 AM through video Conference or other Audio-visual means (OAVM)
  • Cut-off date for determining shareholders entitled to vote: Monday, 3 August 2026

Meeting Details

  • Date: Saturday, 4 July 2026
  • Time: 3:00 p.m. to 4:10 p.m.
  • Venue: Registered Office at 6-3-354/13/B2, Suryateja Apartments, Hindinagar, Punjagutta, Hyderabad - 500082, Telangana